By November 2023, the Drug Supply Chain Security Act (DSCSA) full traceability will come into force with profound impacts on the pharmaceutical industry. Manufacturers, repackagers, wholesale distributors, dispensers and third-party logistics service providers need to establish traceability for all the Rx products that are sold in the U.S. The 2023 deadline is not far away as there are efforts required on numerous fronts to be compliant. Stakeholders need an interoperable system that supports data exchange across multiple business processes, systems and partners in an efficient manner. Many participants in the industry have already started their journey towards full DSCSA 2023 compliance.
In our expert session with Kevan MacKenzie, Upender Solanki and Mark Highhouse, we are covering many critical areas you need to consider for full DSCSA compliance. In an interactive conversation, we will do a deep dive on the DSCSA 2023 requirements, best practices and a recommendation for the high-level technology architecture.
You’ll take away how to assess your readiness for 2023 and benefit from:
- Guidance on DSCSA full traceability requirements
- Implementation of best practices for an interoperable and optimized solution
- An actionable checklist to get started